Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3Breast 3Thoracic 2Gastrointestinal 2Other neoplasm 1Gynecologic 1Genitourinary 1

Conditions

Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Mouth Neoplasms 1Hypotension 1Head and Neck Neoplasms 1Goiter 1

Interventions

Cisplatin 416Radiotherapy 240Radiotherapy, Intensity-Modulated 178Cetuximab 177Docetaxel 166pembrolizumab 148Carboplatin 121Fluorouracil 113Paclitaxel 90Nivolumab 82Gemcitabine 82Radiation 72Surveys and Questionnaires 71Drug Therapy 70toripalimab 68Surgical Procedures, Operative 64Magnetic Resonance Spectroscopy 63Capecitabine 50Blood Specimen Collection 50Chemoradiotherapy 46Biopsy 44camrelizumab 41durvalumab 40Radiosurgery 40Standard of Care 38Erlotinib Hydrochloride 34nimotuzumab 32130-nm albumin-bound paclitaxel 32tislelizumab 31apatinib 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Epinephrine × Head & Neck × Clear all
NCT07392580 2026-06-01

Intralesional Chemotherapy (IC): Cisplatin + Epinephrine

University of Miami

Phase 2 Recruiting
20 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT02112370 2017-08-04

REBT

Seoul National University Hospital

Phase 3 Completed
148 enrolled 17 charts
Head & Neck

Goiter, Thyroid Neoplasms

NCT01418118 2011-08-16

Free4Flow

Oxford University Hospitals NHS Trust

Phase 4 Completed
25 enrolled
Head & Neck

Head and Neck Neoplasms, Hypotension, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡